108 related articles for article (PubMed ID: 9815773)
1. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
[TBL] [Abstract][Full Text] [Related]
3. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
[TBL] [Abstract][Full Text] [Related]
4. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
Jones A; Fujiyama C; Turner K; Cranston D; Williams K; Stratford I; Bicknell R; Harris AL
J Urol; 2002 Mar; 167(3):1482-6. PubMed ID: 11832774
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
[TBL] [Abstract][Full Text] [Related]
6. Different angiogenic pathways characterize superficial and invasive bladder cancer.
O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
Cancer Res; 1995 Feb; 55(3):510-3. PubMed ID: 7530595
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
8. Expression of thymidine phosphorylase in human superficial bladder cancer.
Shimabukuro T; Matsuyama H; Baba Y; Jojima K; Suyama K; Aoki A; Suga A; Yamamoto N; Naito K
Int J Urol; 2005 Jan; 12(1):29-34. PubMed ID: 15661051
[TBL] [Abstract][Full Text] [Related]
9. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
[TBL] [Abstract][Full Text] [Related]
12. [The significance of platelet-derived endothelial cell growth factor mRNA expression in superficial bladder cancer].
Li G; Zhang YF; Ding Q; Yan CY; Wen DG
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(8):478-81. PubMed ID: 15144643
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
Okumura A; Mizuno I; Nagakawa O; Fuse H
Int J Urol; 2004 Dec; 11(12):1082-6. PubMed ID: 15663679
[TBL] [Abstract][Full Text] [Related]
14. [Orotate phosphoribosyl transferase in bladder cancer].
Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Gotanda T; Haraguchi M; Tachiwada T; Shinkura R; Koriyama C; Akiba S; Kawahara M; Nishiyama K; Sumizawa T; Furukawa T; Mimata H; Nomura Y; Akiyama S; Nakagawa M
Int J Mol Med; 2006 Jun; 17(6):1085-91. PubMed ID: 16685420
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
18. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
[TBL] [Abstract][Full Text] [Related]
19. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma.
Ueda T; Tamaki M; Ogawa O; Yoshimura N
J Urol; 2002 Jan; 167(1):347-51. PubMed ID: 11743354
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in human bladder cancer.
Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
